IBDEI17B ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,19518,2)
;;=^5019488
;;^UTILITY(U,$J,358.3,19519,0)
;;=I69.320^^67^877^2
;;^UTILITY(U,$J,358.3,19519,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19519,1,3,0)
;;=3^Aphasia following cerebral infarction
;;^UTILITY(U,$J,358.3,19519,1,4,0)
;;=4^I69.320
;;^UTILITY(U,$J,358.3,19519,2)
;;=^5007491
;;^UTILITY(U,$J,358.3,19520,0)
;;=I69.120^^67^877^3
;;^UTILITY(U,$J,358.3,19520,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19520,1,3,0)
;;=3^Aphasia following nontraumatic intracerebral hemorrhage
;;^UTILITY(U,$J,358.3,19520,1,4,0)
;;=4^I69.120
;;^UTILITY(U,$J,358.3,19520,2)
;;=^5007427
;;^UTILITY(U,$J,358.3,19521,0)
;;=I69.020^^67^877^4
;;^UTILITY(U,$J,358.3,19521,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19521,1,3,0)
;;=3^Aphasia following nontraumatic subarachnoid hemorrhage
;;^UTILITY(U,$J,358.3,19521,1,4,0)
;;=4^I69.020
;;^UTILITY(U,$J,358.3,19521,2)
;;=^5007395
;;^UTILITY(U,$J,358.3,19522,0)
;;=I69.820^^67^877^5
;;^UTILITY(U,$J,358.3,19522,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19522,1,3,0)
;;=3^Aphasia following other cerebrovascular disease
;;^UTILITY(U,$J,358.3,19522,1,4,0)
;;=4^I69.820
;;^UTILITY(U,$J,358.3,19522,2)
;;=^5007522
;;^UTILITY(U,$J,358.3,19523,0)
;;=I69.220^^67^877^6
;;^UTILITY(U,$J,358.3,19523,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19523,1,3,0)
;;=3^Aphasia following other nontraumatic intracranial hemorrhage
;;^UTILITY(U,$J,358.3,19523,1,4,0)
;;=4^I69.220
;;^UTILITY(U,$J,358.3,19523,2)
;;=^5007459
;;^UTILITY(U,$J,358.3,19524,0)
;;=I69.290^^67^877^11
;;^UTILITY(U,$J,358.3,19524,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19524,1,3,0)
;;=3^Apraxia following other nontraumatic intracranial hemorrhage
;;^UTILITY(U,$J,358.3,19524,1,4,0)
;;=4^I69.290
;;^UTILITY(U,$J,358.3,19524,2)
;;=^5007484
;;^UTILITY(U,$J,358.3,19525,0)
;;=I69.390^^67^877^7
;;^UTILITY(U,$J,358.3,19525,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19525,1,3,0)
;;=3^Apraxia following cerebral infarction
;;^UTILITY(U,$J,358.3,19525,1,4,0)
;;=4^I69.390
;;^UTILITY(U,$J,358.3,19525,2)
;;=^5007515
;;^UTILITY(U,$J,358.3,19526,0)
;;=I69.190^^67^877^8
;;^UTILITY(U,$J,358.3,19526,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19526,1,3,0)
;;=3^Apraxia following nontraumatic intracerebral hemorrhage
;;^UTILITY(U,$J,358.3,19526,1,4,0)
;;=4^I69.190
;;^UTILITY(U,$J,358.3,19526,2)
;;=^5007452
;;^UTILITY(U,$J,358.3,19527,0)
;;=I69.090^^67^877^9
;;^UTILITY(U,$J,358.3,19527,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19527,1,3,0)
;;=3^Apraxia following nontraumatic subarachnoid hemorrhage
;;^UTILITY(U,$J,358.3,19527,1,4,0)
;;=4^I69.090
;;^UTILITY(U,$J,358.3,19527,2)
;;=^5007420
;;^UTILITY(U,$J,358.3,19528,0)
;;=I69.890^^67^877^10
;;^UTILITY(U,$J,358.3,19528,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19528,1,3,0)
;;=3^Apraxia following other cerebrovascular disease
;;^UTILITY(U,$J,358.3,19528,1,4,0)
;;=4^I69.890
;;^UTILITY(U,$J,358.3,19528,2)
;;=^5007546
;;^UTILITY(U,$J,358.3,19529,0)
;;=I69.393^^67^877^12
;;^UTILITY(U,$J,358.3,19529,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,19529,1,3,0)
;;=3^Ataxia following cerebral infarction
;;^UTILITY(U,$J,358.3,19529,1,4,0)
;;=4^I69.393
;;^UTILITY(U,$J,358.3,19529,2)
;;=^5007518
;;^UTILITY(U,$J,358.3,19530,0)
;;=I69.193^^67^877^13
;;^UTILITY(U,$J,358.3,19530,1,0)
;;=^358.31IA^4^2
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI17B 3753 printed Apr 09, 2024@21:33:10 Page 2
IBDEI17B ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,19518,2)
+2 ;;=^5019488
+3 ;;^UTILITY(U,$J,358.3,19519,0)
+4 ;;=I69.320^^67^877^2
+5 ;;^UTILITY(U,$J,358.3,19519,1,0)
+6 ;;=^358.31IA^4^2
+7 ;;^UTILITY(U,$J,358.3,19519,1,3,0)
+8 ;;=3^Aphasia following cerebral infarction
+9 ;;^UTILITY(U,$J,358.3,19519,1,4,0)
+10 ;;=4^I69.320
+11 ;;^UTILITY(U,$J,358.3,19519,2)
+12 ;;=^5007491
+13 ;;^UTILITY(U,$J,358.3,19520,0)
+14 ;;=I69.120^^67^877^3
+15 ;;^UTILITY(U,$J,358.3,19520,1,0)
+16 ;;=^358.31IA^4^2
+17 ;;^UTILITY(U,$J,358.3,19520,1,3,0)
+18 ;;=3^Aphasia following nontraumatic intracerebral hemorrhage
+19 ;;^UTILITY(U,$J,358.3,19520,1,4,0)
+20 ;;=4^I69.120
+21 ;;^UTILITY(U,$J,358.3,19520,2)
+22 ;;=^5007427
+23 ;;^UTILITY(U,$J,358.3,19521,0)
+24 ;;=I69.020^^67^877^4
+25 ;;^UTILITY(U,$J,358.3,19521,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,19521,1,3,0)
+28 ;;=3^Aphasia following nontraumatic subarachnoid hemorrhage
+29 ;;^UTILITY(U,$J,358.3,19521,1,4,0)
+30 ;;=4^I69.020
+31 ;;^UTILITY(U,$J,358.3,19521,2)
+32 ;;=^5007395
+33 ;;^UTILITY(U,$J,358.3,19522,0)
+34 ;;=I69.820^^67^877^5
+35 ;;^UTILITY(U,$J,358.3,19522,1,0)
+36 ;;=^358.31IA^4^2
+37 ;;^UTILITY(U,$J,358.3,19522,1,3,0)
+38 ;;=3^Aphasia following other cerebrovascular disease
+39 ;;^UTILITY(U,$J,358.3,19522,1,4,0)
+40 ;;=4^I69.820
+41 ;;^UTILITY(U,$J,358.3,19522,2)
+42 ;;=^5007522
+43 ;;^UTILITY(U,$J,358.3,19523,0)
+44 ;;=I69.220^^67^877^6
+45 ;;^UTILITY(U,$J,358.3,19523,1,0)
+46 ;;=^358.31IA^4^2
+47 ;;^UTILITY(U,$J,358.3,19523,1,3,0)
+48 ;;=3^Aphasia following other nontraumatic intracranial hemorrhage
+49 ;;^UTILITY(U,$J,358.3,19523,1,4,0)
+50 ;;=4^I69.220
+51 ;;^UTILITY(U,$J,358.3,19523,2)
+52 ;;=^5007459
+53 ;;^UTILITY(U,$J,358.3,19524,0)
+54 ;;=I69.290^^67^877^11
+55 ;;^UTILITY(U,$J,358.3,19524,1,0)
+56 ;;=^358.31IA^4^2
+57 ;;^UTILITY(U,$J,358.3,19524,1,3,0)
+58 ;;=3^Apraxia following other nontraumatic intracranial hemorrhage
+59 ;;^UTILITY(U,$J,358.3,19524,1,4,0)
+60 ;;=4^I69.290
+61 ;;^UTILITY(U,$J,358.3,19524,2)
+62 ;;=^5007484
+63 ;;^UTILITY(U,$J,358.3,19525,0)
+64 ;;=I69.390^^67^877^7
+65 ;;^UTILITY(U,$J,358.3,19525,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,19525,1,3,0)
+68 ;;=3^Apraxia following cerebral infarction
+69 ;;^UTILITY(U,$J,358.3,19525,1,4,0)
+70 ;;=4^I69.390
+71 ;;^UTILITY(U,$J,358.3,19525,2)
+72 ;;=^5007515
+73 ;;^UTILITY(U,$J,358.3,19526,0)
+74 ;;=I69.190^^67^877^8
+75 ;;^UTILITY(U,$J,358.3,19526,1,0)
+76 ;;=^358.31IA^4^2
+77 ;;^UTILITY(U,$J,358.3,19526,1,3,0)
+78 ;;=3^Apraxia following nontraumatic intracerebral hemorrhage
+79 ;;^UTILITY(U,$J,358.3,19526,1,4,0)
+80 ;;=4^I69.190
+81 ;;^UTILITY(U,$J,358.3,19526,2)
+82 ;;=^5007452
+83 ;;^UTILITY(U,$J,358.3,19527,0)
+84 ;;=I69.090^^67^877^9
+85 ;;^UTILITY(U,$J,358.3,19527,1,0)
+86 ;;=^358.31IA^4^2
+87 ;;^UTILITY(U,$J,358.3,19527,1,3,0)
+88 ;;=3^Apraxia following nontraumatic subarachnoid hemorrhage
+89 ;;^UTILITY(U,$J,358.3,19527,1,4,0)
+90 ;;=4^I69.090
+91 ;;^UTILITY(U,$J,358.3,19527,2)
+92 ;;=^5007420
+93 ;;^UTILITY(U,$J,358.3,19528,0)
+94 ;;=I69.890^^67^877^10
+95 ;;^UTILITY(U,$J,358.3,19528,1,0)
+96 ;;=^358.31IA^4^2
+97 ;;^UTILITY(U,$J,358.3,19528,1,3,0)
+98 ;;=3^Apraxia following other cerebrovascular disease
+99 ;;^UTILITY(U,$J,358.3,19528,1,4,0)
+100 ;;=4^I69.890
+101 ;;^UTILITY(U,$J,358.3,19528,2)
+102 ;;=^5007546
+103 ;;^UTILITY(U,$J,358.3,19529,0)
+104 ;;=I69.393^^67^877^12
+105 ;;^UTILITY(U,$J,358.3,19529,1,0)
+106 ;;=^358.31IA^4^2
+107 ;;^UTILITY(U,$J,358.3,19529,1,3,0)
+108 ;;=3^Ataxia following cerebral infarction
+109 ;;^UTILITY(U,$J,358.3,19529,1,4,0)
+110 ;;=4^I69.393
+111 ;;^UTILITY(U,$J,358.3,19529,2)
+112 ;;=^5007518
+113 ;;^UTILITY(U,$J,358.3,19530,0)
+114 ;;=I69.193^^67^877^13
+115 ;;^UTILITY(U,$J,358.3,19530,1,0)
+116 ;;=^358.31IA^4^2
